Entering the market this week is the newly Food-and-Drug-Administration-approved Alipazone — brand name: Ablixa — an antidepressant drug of the “selective serotonin reuptake inhibitor (SSRI) class” that has been produced to treat major depression, and is prescribed off-label for other conditions. The logo, packaging, and advertising have been designed by Pentagram partner Emily Oberman.
About: (Est. 1956) “Actavis [combination of Watson Pharmaceuticals, Inc. and the Actavis Group] is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company has global and U.S. headquarters in Parsippany, New Jersey, USA, and international headquarters in Zug, Switzerland. Actavis is the world’s third-largest generics prescription drug manufacturer.”
Design by: Lippincott.
Ed.’s Notes: Bigger view of the logo below (or after the jump).
Select quote: “Our new icon speaks to our Company’s fast-evolving business, as well as its dynamic culture. A close look reveals a “W” shape emerging from a shaded “A”, a subtle historical reference to the Watson heritage and acquisition of Actavis.
Our new color stands out in the universe of pharmaceutical industry competitors and reflects growth — a fundamental foundation for our Company and its future. The result is a new, powerful and accessible visualization that celebrates our Company’s emergence as a global pharmaceutical leader, and visually defines our focus on growth and success in the future.”